Legochem Bioscience said that it has signed a research collaboration and license option agreement to develop an antibody-drug conjugate (ADC) treatment with Antengene Biologics, a Chinese biopharmaceutical company.The two companies plan to discover ADC candidates using Antengene's antibodies and Leg
Boryung Pharmaceutical said that it has acquired all local rights, including sales and licensing, concerning Lilly's schizophrenia treatment Zyprexa (ingredient name: olanzapine).Zyprexa, launched in 1996, is the most prescribed treatment for schizophrenia.Hospitals use the drug to treat schizophren
Shinpoong Pharmaceutical said it registered the first patient for the domestic phase 3 trial of Pyramax (pyronaridine/artesunate), an oral drug for Covid-19 treatment.“At around 7 p.m. on Monday, we enrolled the first Korean patient for the phase 3 study at Sahmyook Medical Center,” an official at S
Merck Life Science, the life science arm of Merck KGaA in Darmstadt, Germany, celebrated the fifth anniversary of its M Lab Collaboration Center in Songdo, Incheon, on Thursday.The center is a non-GMP facility, equipped and designed to recreate the manufacturing environment, evaluate and resolve pro
SK Plasma, a subsidiary of SK Discovery, said that it has won the national bid to supply blood products to Singapore."This is the first time a Korean pharmaceutical company has won a national bid for blood products in Singapore," the company said. "Until now, multinational pharmaceutical companies h
CancerRop, which specializes in genetic analysis and molecular diagnostics, said Thursday that it signed a 3 billion won ($2.55-million) contract with COREE Company to collaborate in immune cell profiling to establish data for developing vaccines.Under the accord, CancerRop will also cooperate with
Two Korean pharmaceutical companies are having difficulties in conducting Covid-19 treatment trials in the Philippines, industry officials said.Korean drug developers had picked the Philippines as the optimal country to test Covid-19 drug candidates because it had many Covid-19 cases. However, along
Hanall Biopharma said Wednesday that Harbour BioMed, its Chinese partner, has started the first patient administration of HL161 (Ingredient: batoclimab), a new autoimmune disease treatment drug for treating thyroid-associated ophthalmopathy.Harbour BioMed plans to evaluate the safety and efficacy of
Korean biopharmaceutical companies’ technology exports are rapidly increasing to China, one of the two largest global pharmaceutical markets along with the U.S.According to the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), the amount of license-out contracts signed with Chin
Eutilex said it has resumed the clinical trial of immunotherapy EBViNT, 30 months after the regulator suspended the trial.The resumption took longer than the market expected, but it draws attention to whether Eutilex will compensate for the delayed development.On Tuesday, the company said that it ad
Daewoong Pharmaceuticals and inno.N, the two Korean frontrunners in potassium-competitive acid blocker (P-CAB) drugs for gastroesophageal reflux disease (GERD), are fiercely competing to carve out a larger share in the global market.inno.N won the title of the first Korean company to develop a new d
Industry watchers are paying attention to whether Daewoong Pharmaceutical will obtain the marketing approval for Fexuprazan, a gastroesophageal reflux treatment.This month, analysts at local investment banks began to raise anticipation for the release of Fexuprazan.Daewoong is waiting for the Minist
DeepBio said that Stanford University’s research team has released study results on DeepDx-Prostate, the company’s deep learning-based software that diagnoses prostate cancer, at the annual meeting of the American Urological Association (AUA).The researchers at Stanford University School of Medicine
The Ministry of Food and Drug Safety and the Korea Customs Service caught 110,000 illegal drugs imported directly from overseas, totaling 69.6 billion won ($58.6 million) over the past five years, a lawmaker said.The two agencies confiscated illegal drugs worth 9.1 billion won last year, according t
Hugel, a Korean aesthetics and therapeutics developer, said the European Medicines Agency (EMA) has completed an on-site inspection of its plant in Chuncheon, Gangwon Province, manufacturing its botulinum toxin (BTX) brand, Letybo.The plant produces more than five million BTX vials a year with the l
An international medical journal published the meta-analysis of studies, including the cardiovascular safety trial of Hanmi Pharmaceutical’s investigational antidiabetic drug, efpeglenatide.Industry watchers are paying attention to whether the publication will be a turning point for the development
The government has extended the current distancing rules for another two weeks ahead of transitioning into the more relaxed "live-with-covid" system from November.Accordingly, the Seoul metro region will be under the Level 4 distancing measures and the non-capital area under Level 3 measures until O
With the global supply chain under duress due to the protracted Covid-19 pandemic, Korean pharmaceutical companies are having difficulty obtaining raw materials, leading to some medicines going out of stock, industry sources said.For example, Yuhan Corp's constipation treatments Portalac powder and
Daewoong Pharmaceutical said it has signed an agreement with Aghrass Healthcare Limited, a United Arab Emirates (UAE)-based company, to license out gastroesophageal reflux treatment, Fexuprazan.Under the accord, Aghrass Healthcare Limited will license and sell Fexuprazan in six Middle Eastern nation
Besremi (ropeginterferon alfa-2b), developed by Taiwanese drugmaker Pharma Essentia, obtained marketing approval in Korea. It is a next-generation interferon that acts directly on hematopoietic stem cells to treat polycythemia vera fundamentally.On Wednesday, the Ministry of Food and Drug Safety app